Last reviewed · How we verify
NCT05654675
Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET
trial testing FDG PET/CT in Lung Cancer in 30 participants. Currently enrolling.
1 April 2025
Quick facts
| Lead sponsor | Academisch Ziekenhuis Maastricht |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 15 January 2024 |
| Primary completion | 1 April 2025 |
| Estimated completion | 1 June 2025 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- FDG PET/CT
Conditions studied
- Lung Cancer — all drugs for Lung Cancer →
- Lymphoma — all drugs for Lymphoma →
Sponsor
Academisch Ziekenhuis Maastricht
Who can join
18 and older, any sex, with Lung Cancer or Lymphoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to evaluate the use of new method to quantify the amount of sugar a tumor consumes using PET/CT. The main questions it aims to answer are: * Is the new quantification method superior with respect to the method currently used in the clinic? * Does the new quantification method provide accurate assessment of the sugar consumption of tumours? Participants who will undergo a standard care FDG PET/CT scan will in additional receive a dynamic PET/CT scan prior to the standard care scan. In addition blood samples will be drawn at three time points during the examination.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Improving image reconstruction to quantify dynamic whole-body PET/CT: Q.Clear versus OSEM.
Springer S, Basset-Sagarminaga J, van de Weijer T, Schrauwen-Hinderling VB, et al · · 2025 · cited 1× · PMID 40140159 · DOI 10.1186/s40658-025-00736-5
Verify or expand the search:
- PubMed search for NCT05654675
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of FDG PET/CT
Trials testing the same drug.
- NCT05000138 — FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis · completed
- NCT04614116 — Cold Induced Futile Cycles In White Adipose Tissue · NA · completed
- NCT04271436 — Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT · Phase 2 · withdrawn
- NCT04685798 — Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparati · NA · terminated
- NCT03777839 — PET-FDG in Myocarditis · completed
Other recruiting trials for Lung Cancer
Currently open trials in the same condition.
- NCT07295821 — Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study · Phase 2 · recruiting
- NCT06909201 — Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigatin · Phase 1 · recruiting
- NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
- NCT07487064 — Galvanize Aliya® EX Pulsed Electric Field (PEF) Treat and Resect Study · NA · recruiting
- NCT07146568 — Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hos · NA · recruiting
Other Academisch Ziekenhuis Maastricht trials
Trials by the same sponsor.
- NCT07533214 — Impact of Left-Handed Tailored Endoscopic Mitral Simulation Training on Skill Acquisition for Left-handed Surgeons · NA · enrolling by invitation
- NCT06341101 — Timely Recovery After Subclinical Heart Failure · Phase 4 · unknown
- NCT04010578 — Effects of VitamIN K2 and D3 supplementaTion on PET/MRI in Carotid Artery Disease · NA · unknown
- NCT05969340 — Detecting Otoconia With CT-Scan · NA · withdrawn
- NCT05931068 — Perioperative Energy Expenditure in Major Liver Resection · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05654675 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Academisch Ziekenhuis Maastricht
- Last refreshed: 29 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05654675.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing